Using placental models to train neurosurgeons for treating brain aneurysms
Official title: Placental Learning Model for Neurovascular Microsurgery for the Management of Intracranial Aneurysms
Run by University Hospital, Strasbourg, France · NCT06117527 · Data updated 2026-11-12
This study is testing whether using placental tissue as a training tool can help neurosurgeons improve their skills in treating brain aneurysms.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Status | Recruiting |
| Started | July 16, 2020 |
| Main results expected | February 2028 |
| Study ends | February 2028 |
| Registry record updated | December 26, 2025 |
| Trial ID | NCT06117527 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are women over the age of 18 who are undergoing procedures where their placenta would be considered surgical waste.
✕Probably not a fit
Patients who have expressed opposition to the reuse of their placenta or those under legal guardianship will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on enhancing the training of neurosurgeons in microsurgical techniques for managing intracranial aneurysms. It utilizes placental tissue, considered surgical waste, to create a simulation model that better replicates the conditions of human anatomy compared to traditional animal models. The aim is to improve surgical skills and confidence in handling complex cases that may arise in clinical practice. The study will involve women over 18 who consent to the use of their placenta for educational purposes.
Why it matters
Potential benefit: If successful, this approach could significantly improve the surgical training of neurosurgeons, leading to better patient outcomes in the management of intracranial aneurysms.
How similar studies have gone: While the use of placental models in surgical training is innovative, similar studies using alternative simulation methods have shown promise in enhancing surgical skills.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: * Woman over the age of 18; * Placenta considered as surgical waste intended for incineration; with a negative infectious status verified during pregnancy follow-up * Woman who did not express her opposition, after information, to the reuse of her placenta for educational purposes to improve the practical training of future neurosurgeons. Exclusion criteria: * Subject who expressed their opposition to participating in the study * Subject under guardianship or curatorship * Subject under safeguard of justice
Where it's running
-
Service de Neurochirurgie - CHU de Strasbourg - France
Strasbourg, France Recruiting
Study contacts
- Study coordinator: Irène OLLIVIER, MD
- Email: irene.ollivier@chru-strasbourg.fr
- Phone: 33 3 88 12 76 24
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Flow Diverter Stent for Intracranial Aneurysm in China
This study tests a novel flow diverter stent to treat intracranial aneurysms in adults and follows patients through treatment and follow-up.
-
Real-World Experience With the WEB Device for Intracranial Aneurysms
This study tests how well the Woven EndoBridge device works in routine treatment of intracranial aneurysms in China across multiple centers.
-
Choydar flow-directed mesh stent for unruptured brain aneurysms
This trial tests the Choydar flow-directed mesh stent to see if it is safe and works for people with unruptured intracranial aneurysms in the internal carotid or vertebral arteries.
-
Pivotal test of the Silk Vista Baby Flow Diverter for unruptured brain aneurysms
This study tests whether the Silk Vista Baby flow diverter can safely and effectively treat a single unruptured intracranial aneurysm in adults 22–80 years old.
-
Pipeline Vantage post-approval safety and outcomes for intracranial aneurysm treatment
This project will test whether the Pipeline Vantage embolization device with Shield Technology is safe and effective for adults treated for intracranial aneurysms.
-
Improving brain intervention planning using vascular mapping
This study is testing new ways to plan brain surgeries for aneurysms and AVMs to make them safer and more effective by using advanced mapping and computer models.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.